Saudi Arabia Liver Cancer Diagnostics Market Size & Outlook
Saudi Arabia liver cancer diagnostics market, 2018-2030 (US$M)
Related Markets
Saudi Arabia liver cancer diagnostics market highlights
- The Saudi Arabia liver cancer diagnostics market generated a revenue of USD 55.9 million in 2023 and is expected to reach USD 64.1 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 2% from 2024 to 2030.
- In terms of segment, outpatient facilities was the largest revenue generating end use in 2023.
- Home Care is the most lucrative end use segment registering the fastest growth during the forecast period.
Liver cancer diagnostics market data book summary
| Market revenue in 2023 | USD 55.9 million |
| Market revenue in 2030 | USD 64.1 million |
| Growth rate | 2% (CAGR from 2023 to 2030) |
| Largest segment | Outpatient facilities |
| Fastest growing segment | Home Care |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
| Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Roche Holding AG ADR, Qiagen NV, Siemens Healthineers AG ADR, Becton Dickinson & Co, Illumina Inc, Epigenomics AG, Koninklijke Philips NV, FUJIFILM Holdings Corp |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 1.0% of the global liver cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia liver cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 26.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Liver Cancer Diagnostics Market Scope
Liver Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia liver cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to liver cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 61% in 2023. Horizon Databook has segmented the Saudi Arabia liver cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
The Saudi Arabia liver cancer diagnostics market growth can primarily be attributed to the various initiatives being undertaken by the government to enable early diagnosis and treatment of several cancers, in particular, liver cancer.
In 2019, Saudi Arabia’s Ministry of Health announced to implement several initiatives, including advancements in screening programs, raising awareness about cancers, and establishing new cancer centers across the region.
Furthermore, according to GLOBOCAN, liver cancer was the fourth most common cause of death due to cancers. In 2018, around 905 new cases of liver cancer were reported in the country, which led to around 852 deaths.
Reasons to subscribe to Saudi Arabia liver cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia liver cancer diagnostics market databook
-
Our clientele includes a mix of liver cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia liver cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia liver cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia liver cancer diagnostics market size, by end use, 2018-2030 (US$M)
Saudi Arabia Liver Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
